Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

Historical Holders from Q3 2020 to Q3 2025

Symbol
DYN on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
141,783,702
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
155,771,786
Holdings value
$1,970,400,036
% of all portfolios
0.006%
Number of holders
204
Number of buys
146
Number of sells
-64
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10.4% +3% $186,530,638 +$4,433,901 14,745,505 +2.4% JANUS HENDERSON GROUP PLC 30 Sep 2025
BlackRock, Inc. 5.8% $73,080,236 6,577,879 BlackRock, Inc. 31 Mar 2025
Atlas Venture Fund XI, L.P. 4% $72,275,396 5,713,470 Atlas Venture Associates XI, L.P. 30 Sep 2025
Forbion Capital Fund IV Cooperatief U.A. 4.8% $60,000,055 5,400,545 ForDyne B.V. 31 Mar 2025
FMR LLC 4.6% -41.2% $57,719,716 -$31,126,187 5,195,294 -35% FMR LLC 31 Mar 2025
RTW INVESTMENTS, LP 1.5% -72% $18,782,199 -$39,196,902 1,690,567 -67.6% RTW Investments, LP 31 Mar 2025
Point72 Asset Management, L.P. 1.5% -72% $18,546,390 -$39,187,803 1,669,342 -67.9% Point72 Asset Management, L.P. 31 Mar 2025

Institutional Holders of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 155,771,786 $1,970,400,036 +$381,733,575 $12.65 204
2025 Q2 128,553,808 $1,223,875,095 +$58,226,785 $9.52 195
2025 Q1 121,788,688 $1,284,331,056 -$75,923,327 $10.46 202
2024 Q4 111,635,776 $2,630,327,572 -$39,471,758 $23.56 199
2024 Q3 112,428,939 $4,033,469,001 -$6,349 $35.92 200
2024 Q2 110,972,098 $3,915,861,443 +$555,159,053 $35.29 191
2024 Q1 95,365,001 $2,707,385,907 +$786,881,972 $28.39 167
2023 Q4 69,922,072 $929,957,219 +$57,596,260 $13.3 123
2023 Q3 59,888,832 $536,594,556 +$1,685,315 $8.96 114
2023 Q2 59,189,838 $665,851,766 +$50,911,029 $11.25 117
2023 Q1 54,627,733 $628,721,822 +$56,536,368 $11.52 125
2022 Q4 49,732,095 $576,377,450 +$50,130,248 $11.59 112
2022 Q3 44,533,854 $565,571,380 -$9,010,573 $12.7 100
2022 Q2 46,679,856 $320,706,640 -$8,056,035 $6.87 87
2022 Q1 47,256,134 $455,432,690 -$4,233,139 $9.64 90
2021 Q4 47,794,946 $568,260,037 +$18,929,604 $11.89 90
2021 Q3 32,306,202 $524,727,164 -$16,367,213 $16.24 80
2021 Q2 35,805,078 $753,366,735 +$36,093,361 $21.04 75
2021 Q1 31,379,394 $487,292,000 +$72,426,450 $15.53 72
2020 Q4 26,339,155 $552,433,805 +$28,795,524 $21 67
2020 Q3 24,527,914 $493,744,000 +$493,744,015 $20.19 49